NCT06660446 Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study. Status RECRUITING Phase NA
NCT06645093 Feasibility of Intermittent Fasting During Chemotherapy Status ENROLLING_BY_INVITATION Phase NA
NCT06643221 Exercise as an Immune Adjuvant for Allogeneic Cell Therapies Status RECRUITING Phase EARLY_PHASE1
NCT06624085 A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status RECRUITING Phase PHASE1
NCT06613230 Improved Early Diagnosis in Female Pelvic Cancer With OC Detect Status COMPLETED Phase N/A
NCT06592170 Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL) Status RECRUITING Phase PHASE1/PHASE2
NCT06585124 Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas Status RECRUITING Phase N/A
NCT06582849 Enhanced Assistance During Radiotherapy for Unmet Essential Needs Status COMPLETED Phase NA
NCT06573151 Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06563505 A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma Status RECRUITING Phase PHASE2
NCT06558513 To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT06557330 MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06550427 Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing Status RECRUITING Phase N/A
NCT06522737 A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype Status RECRUITING Phase PHASE3
NCT06510361 Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy Status RECRUITING Phase PHASE2